GO Term |
---|
cellular response to cadmium ion |
cellular response to epidermal growth factor stimulus |
cellular response to estradiol stimulus |
GO Term |
---|
Golgi membrane |
endosome |
endoplasmic reticulum membrane |
basal plasma membrane |
cell surface |
basolateral plasma membrane |
apical plasma membrane |
perinuclear region of cytoplasm |
extracellular space |
nucleus |
GO Term |
---|
ATP binding |
enzyme binding |
kinase binding |
protein kinase binding |
protein phosphatase binding |
ubiquitin protein ligase binding |
identical protein binding |
cadherin binding |
epidermal growth factor binding |
actin filament binding |
Position | Description | PubMed ID | GlyTouCan ID | Source |
---|---|---|---|---|
56 | N-linked (GlcNAc...) (complex) asparagine; atypical; partial | |||
73 | N-linked (GlcNAc...) asparagine; atypical |
|
||
128 | N-linked (GlcNAc...) asparagine | |||
175 | N-linked (GlcNAc...) asparagine | |||
196 | N-linked (GlcNAc...) asparagine | |||
271 |
|
|||
352 | N-linked (GlcNAc...) asparagine | |||
361 | N-linked (GlcNAc...) asparagine | |||
364 |
|
|||
380 |
|
Pathway Name | Organism |
---|---|
Cargo recognition for clathrin-mediated endocytosis | Homo sapiens |
Clathrin-mediated endocytosis | Homo sapiens |
Constitutive Signaling by Aberrant PI3K in Cancer | Homo sapiens |
Constitutive Signaling by EGFRvIII | Homo sapiens |
Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | Homo sapiens |
Downregulation of ERBB2 signaling | Homo sapiens |
EGFR Transactivation by Gastrin | Homo sapiens |
EGFR downregulation | Homo sapiens |
EGFR interacts with phospholipase C-gamma | Homo sapiens |
ERBB2 Activates PTK6 Signaling | Homo sapiens |
Tissue with high expression from Human Protein Atlas. Tissues that are highly expressed are highlighted.
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.1.0
Last updated: December 9, 2024